Sunpill maker rejects NAD’s finding
This article was originally published in The Tan Sheet
Executive Summary
The National Advertising Division May 10 says it will refer Pure Pharmaceuticals to the Federal Trade Commission for possible enforcement action after the Miami-based firm declined to fully comply with NAD's recommendations for changes in claims for its Sunpillproduct. NAD contacted Pure in March to question why claims it challenged in a compliance review remained on the firm's Web site. Pure provided a list of changes it made, but NAD said it "remained concerned that the advertising continues to convey the message that sunscreen is unnecessary, does not provide adequate protection against the sun or that Sunpill is the first line of defense in sun protection." Disclosures the firm added "contradict the claims they are intended to qualify" or "are not in close proximity to the underlying claims," NAD said, adding its procedures require it to refer firms to FTC if they fail to comply with its recommendations...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.